{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:48:07Z","timestamp":1770353287454,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.anndiagpath.2023.152211","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T21:33:29Z","timestamp":1694640809000},"page":"152211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors"],"prefix":"10.1016","volume":"67","author":[{"given":"Dusan","family":"Rasic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Korsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Marcussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Magrethe","family":"Precht Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2023.152211_bb0005","article-title":"Pathologists\u2019 diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.humpath.2013.02.007","article-title":"Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update","volume":"45","author":"Ord\u00f3\u00f1ez","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40291-018-0318-z","article-title":"Emerging biomarkers in cutaneous melanoma","volume":"22","author":"Eisenstein","year":"2018","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0025","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0030","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/cup.13818","article-title":"PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features","volume":"47","author":"Raghavan","year":"2020","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0035","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/diagnostics12092197","article-title":"PRAME immunoexpression in 275 cutaneous melanocytic lesions: a double institutional experience","volume":"12","author":"Cazzato","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0040","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.3390\/cancers13153864","article-title":"Diffuse PRAME expression is highly specific for thin melanomas in the distinction from severely dysplastic nevi but does not distinguish metastasizing from non-metastasizing thin melanomas","volume":"13","author":"Gassenmaier","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0045","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/his.14814","article-title":"PRAME is a useful marker for the differential diagnosis of melanocytic tumours and histological mimics","volume":"82","author":"Chen","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.path.2021.01.001","article-title":"PRAME immunohistochemistry as an ancillary test for the assessment of melanocytic lesions","volume":"14","author":"Lezcano","year":"2021","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cup.13958","article-title":"The utility of PRAME staining in identifying malignant transformation of melanocytic nevi","volume":"48","author":"Lohman","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/his.14904","article-title":"Diagnostic test accuracy meta-analysis of PRAME in distinguishing primary cutaneous melanomas from benign melanocytic lesions","volume":"83","author":"Kunc","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0065","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/cup.14286","article-title":"PRAME expression is similar in scar and desmoplastic melanoma","volume":"49","author":"Plotzke","year":"2022","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0749.2005.00269.x","article-title":"The silver locus product Pmel17\/gp100\/Silv\/ME20: controversial in name and in function","volume":"18","author":"Theos","year":"2005","journal-title":"Pigment Cell Res"},{"issue":"Suppl. 2","key":"10.1016\/j.anndiagpath.2023.152211_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0560.2008.01130.x","article-title":"Use of immunohistochemistry in melanocytic lesions","volume":"35","author":"Prieto","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0560.2007.00891.x","article-title":"Immunohistochemical characteristics of melanoma","volume":"35","author":"Ohsie","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0085","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.3390\/ijms23115911","article-title":"Cutaneous melanomas: a single center experience on the usage of immunohistochemistry applied for the diagnosis","volume":"23","author":"Ricci","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0090","author":"Elder DE, cancer C international de recherche sur le, Board WHOCWHOCTE"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0095","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/sim.8829","article-title":"Confidence intervals for difference in proportions for matched pairs compatible with exact McNemar\u2019s or sign tests","volume":"40","author":"Fay","year":"2021","journal-title":"Stat Med"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0110","author":"Fay"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0115","author":"Haile"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000372-199113060-00004","article-title":"HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation","volume":"13","author":"Skelton","year":"1991","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0130","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.3390\/ijms21249583","article-title":"Melanoma biomarkers and their potential application for in vivo diagnostic imaging modalities","volume":"21","author":"Hessler","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13000-015-0431-9","article-title":"A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"10","author":"Uguen","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/DAD.0000000000001645","article-title":"Three types of nodal melanocytic nevi in sentinel lymph nodes of patients with melanoma: pitfalls, immunohistochemistry, and a review of the literature","volume":"42","author":"Gonz\u00e0lez-Farr\u00e9","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0145","first-page":"621","article-title":"Application of immunohistochemical staining of PRAME in differential diagnosis between melanoma and melanocytic nevus","volume":"51","author":"Du","year":"2022","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0150","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaad.2019.12.020","article-title":"Pathologists\u2019 agreement on treatment suggestions for melanocytic skin lesions","volume":"82","author":"Jafry","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0155","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/cup.13916","article-title":"Aberrant expression of HMB45 and negative PRAME expression in halo nevi","volume":"48","author":"Ruby","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2023.152211_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAI.0000000000000972","article-title":"HMB45\/PRAME, a novel double staining for the diagnosis of melanocytic neoplasms: technical aspects, results, and comparison with other commercially available staining (PRAME and Melan A\/PRAME)","volume":"30","author":"Grillini","year":"2022","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913423001090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913423001090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:36:12Z","timestamp":1761078972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913423001090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":30,"alternative-id":["S1092913423001090"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2023.152211","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2023.152211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152211"}}